← back to search

Debby Ngo

Novartis (Switzerland) · CH
Area of research
Spectroscopy · Molecular Biology
Research interest
Research interests include Advanced Proteomics Techniques and Applications, Metabolomics and Mass Spectrometry Studies, Genetic Associations and Epidemiology, and COVID-19 Clinical Research Studies.
h-index
31
citations
3,774
works
106
NIH funding
primary concept
email

Recent publications

Protein-metabolite association studies identify novel proteomic determinants of metabolite levels in human plasma
Cell Metabolism 2023cited by 56position: middledoi
Protein Markers of Diabetes Discovered in an African American Cohort
Diabetes 2023cited by 16position: middledoi
Systemic Markers of Lung Function and Forced Expiratory Volume in 1 Second Decline across Diverse Cohorts
Annals of the American Thoracic Society 2023cited by 11position: firstdoi
Whole Genome Association Study of the Plasma Metabolome Identifies Metabolites Linked to Cardiometabolic Disease in Black Individuals
Nature Communications 2022cited by 61position: middledoi
Transcriptional Dysregulation Underlies Both Monogenic Arrhythmia Syndrome and Common Modifiers of Cardiac Repolarization
Circulation 2022cited by 29position: middledoi
Proteomics and Population Biology in the Cardiovascular Health Study (CHS): design of a study with mentored access and active data sharing
European Journal of Epidemiology 2022cited by 27position: middledoi
Nontargeted and Targeted Metabolomic Profiling Reveals Novel Metabolite Biomarkers of Incident Diabetes in African Americans
Diabetes 2022cited by 26position: middledoi
Development and validation of a metabolite index for obstructive sleep apnea across race/ethnicities
Scientific Reports 2022cited by 23position: middledoi
Longitudinal proteomic analysis of severe COVID-19 reveals survival-associated signatures, tissue-specific cell death, and cell-cell interactions
Cell Reports Medicine 2021cited by 309position: middledoi
Proteomic profiling reveals biomarkers and pathways in type 2 diabetes risk
JCI Insight 2021cited by 81position: firstdoi
Metabolomic Analysis of Coronary Heart Disease in an African American Cohort From the Jackson Heart Study
JAMA Cardiology 2021cited by 48position: middledoi
Multiomic Profiling in Black and White Populations Reveals Novel Candidate Pathways in Left Ventricular Hypertrophy and Incident Heart Failure Specific to Black Adults
Circulation Genomic and Precision Medicine 2021cited by 25position: middledoi
Whole-genome sequencing in diverse subjects identifies genetic correlates of leukocyte traits: The NHLBI TOPMed program
The American Journal of Human Genetics 2021cited by 25position: middledoi
Comparison of Proteomic Assessment Methods in Multiple Cohort Studies
PROTEOMICS 2020cited by 183position: middledoi
Glycerol-3-phosphate is an FGF23 regulator derived from the injured kidney
Journal of Clinical Investigation 2020cited by 124position: middledoi
Proteomic and Metabolomic Correlates of Healthy Dietary Patterns: The Framingham Heart Study
Nutrients 2020cited by 78position: middledoi
Aptamer-Based Proteomic Platform Identifies Novel Protein Predictors of Incident Heart Failure and Echocardiographic Traits
Circulation Heart Failure 2020cited by 53position: middledoi
Proteomic Signatures of Lifestyle Risk Factors for Cardiovascular Disease: A Cross‐Sectional Analysis of the Plasma Proteome in the Framingham Heart Study
Journal of the American Heart Association 2020cited by 43position: middledoi
Circulating testican-2 is a podocyte-derived marker of kidney health
Proceedings of the National Academy of Sciences 2020cited by 36position: firstdoi
Profiling of the plasma proteome across different stages of human heart failure
Nature Communications 2019cited by 89position: middledoi
Proteomics Profiling and Risk of New‐Onset Atrial Fibrillation: Framingham Heart Study
Journal of the American Heart Association 2019cited by 64position: middledoi
Genetic Architecture of the Cardiovascular Risk Proteome
Circulation 2017cited by 81position: middledoi
Aptamer-Based Proteomic Profiling Reveals Novel Candidate Biomarkers and Pathways in Cardiovascular Disease
Circulation 2016cited by 215position: firstdoi
2-Aminoadipic acid is a biomarker for diabetes risk
Journal of Clinical Investigation 2013cited by 466position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Robert E. Gerszten · Broad Institute15 papers (2013–2023)Mark D. Benson · Beth Israel Deaconess Medical Center10 papers (2016–2023)Thomas J. Wang · Wayne State University9 papers (2013–2021)Ramachandran S. Vasan · Department of Public Health9 papers (2013–2021)Martin G. Larson · AdventHealth Tampa8 papers (2013–2021)Dongxiao Shen · Beth Israel Deaconess Medical Center7 papers (2016–2023)Qiong Yang · Boston University7 papers (2017–2021)Sumita Sinha · All India Institute of Medical Sciences, Deoghar7 papers (2013–2021)Michelle J. Keyes · Beth Israel Deaconess Medical Center6 papers (2016–2023)Clary B. Clish · Broad Institute6 papers (2013–2022)Adolfo Correa · Jackson Memorial Hospital5 papers (2020–2023)Laurie Farrell · Beth Israel Deaconess Medical Center5 papers (2016–2023)Yan Gao · Harbin Medical University5 papers (2020–2023)Daniel E. Cruz · Beth Israel Deaconess Medical Center4 papers (2021–2023)Usman A. Tahir · Beth Israel Deaconess Medical Center4 papers (2021–2023)Daniel H. Katz · Stanford University4 papers (2020–2022)Zsu‐Zsu Chen · Beth Israel Deaconess Medical Center4 papers (2021–2023)Xu Shi · Beth Israel Deaconess Medical Center4 papers (2016–2022)Bennet Peterson · Institute of Human Genetics4 papers (2020–2022)Honghuang Lin · Native American Cancer Initiatives (United States)3 papers (2019–2020)